Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Investment in material subsidiary and working capital
A portion of the fresh issue proceeds was earmarked to fund the working capital needs of the company's material subsidiary, supporting its ongoing store operations and inventory.
General corporate purposes
The balance of the fresh issue proceeds was set aside for general corporate purposes.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
MedPlus Health Services is a pharmacy retail chain founded in 2006 that operates a large network of branded pharmacy stores. Its outlets combine prescription and over the counter medicines with wellness products, medical devices and everyday household and personal care items, positioning the chain as a one stop store for routine healthcare and daily essentials rather than just a medicine counter. The company was started by Gangadi Madhukar Reddy, who continues to lead it, and grew from a small cluster of stores in Hyderabad into one of the largest pharmacy retail networks in India. By the time of its stock market debut in December 2021, it operated more than two thousand stores spread across seven states, including Telangana, Andhra Pradesh, Tamil Nadu, Karnataka, Odisha, West Bengal and Maharashtra. The business relies on its own supply chain, warehousing and technology systems to manage inventory, pricing and store operations across this large network, and describes itself as India's second largest pharmacy retailer by both store count and revenue. Its growth approach centers on adding stores within existing city clusters to deepen density, expanding its own label and general merchandise range alongside pharmaceuticals, and using in house logistics and point of sale systems to keep operating costs down as the chain scales.
Ahead of the offer, the company raised about Rs 417.99 crore from anchor investors at the cap price of Rs 796 per share. Participants included global institutions such as the Abu Dhabi Investment Authority, BlackRock Global Funds, Goldman Sachs, Morgan Stanley, Fidelity, Nomura, Wasatch and Carmignac, alongside domestic investors including HDFC, ICICI Prudential, SBI and Nippon Life mutual funds and insurers.
Source: RHP • Analysis provided for informational purposes
Last Updated: 21 July 2026, 2:15 AM
Strengths are not available
Rich valuation versus near-term earnings
The issue was priced at a demanding multiple relative to trailing profits, with investors depending on the company sustaining the unusually strong earnings growth seen just before the offer rather than reverting to its earlier, lower profitability.
Medplus Health Services Limited
H. No 11-6-56, Survey No 257 and 258/1, Opposite IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad, Telangana 500037, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.